Texas Tech University Health Sciences Center (Lubbock)
Hematology and Oncology fellowship · Lubbock, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Texas Tech University Health Sciences Center's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About Texas Tech University Health Sciences Centerinstitution-wide hematology and oncology research
Hematology and Oncology publications from Texas Tech University Health Sciences Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
76
works per year
44th of 74 hematology and oncology fellowship programs
+23.5%
2-year growth
18th of 74 hematology and oncology fellowship programs
16.5%
in top 10% of field (works before 2025)
56th of 72 hematology and oncology fellowship programs
34.4%
cited above world average
56th of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 297Hematology · 109
Hematology and Oncology research topics at Texas Tech University Health Sciences Center
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 46
- Acute Myeloid Leukemia Research 42
- Global Cancer Incidence and Screening 36
- Cutaneous Melanoma Detection and Management 33
- Colorectal Cancer Screening and Detection 27
- Multiple Myeloma Research and Treatments 25
- Pancreatic and Hepatic Oncology Research 23
- Drug Transport and Resistance Mechanisms 22
Most cited at Texas Tech University Health Sciences Center since 2024
All hematology and oncology papers there on OpenAlex
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021Pojsakorn Danpanichkul et al. · Gut · 2024 · PubMed · cited 165
- American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendationsJorge D. Machicado et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 60
- Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countriesPojsakorn Danpanichkul et al. · Cancer · 2025 · PubMed · cited 45
- Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic reviewLakshmi Prasanna Vaishnavi Kattamuri et al. · Rheumatology International · 2025 · PubMed · cited 41
- Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Acute Decompensated Heart Failure: A Meta-AnalysisSong Peng Ang et al. · Journal of Clinical Medicine · 2024 · PubMed · cited 33
- Global epidemiology of early‐onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019Pojsakorn Danpanichkul et al. · Journal of Gastroenterology and Hepatology · 2024 · PubMed · cited 32
- CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancerGanesh Acharya et al. · Cell Death Discovery · 2024 · PubMed · cited 31
- The Burden of Overweight and Obesity-Associated Gastrointestinal Cancers in Low and Lower-Middle-Income Countries: A Global Burden of Disease 2019 AnalysisPojsakorn Danpanichkul et al. · The American Journal of Gastroenterology · 2024 · PubMed · cited 30
- Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutationsMithun Vinod Shah et al. · Blood Advances · 2025 · PubMed · cited 23
- Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapiesSarra Mestiri et al. · Cancer and Metastasis Reviews · 2025 · PubMed · cited 21